MedTrace Logo

Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration

NCT00338078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2008-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether oxygen therapy during sleep improves quality of life, exercise capacity and heart function among patients with chronic heart failure and central sleep apnea.

Conditions

Interventions

DEVICE

nocturnal oxygen treatment from oxygen concentrators

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Karl A Franklin, MD, PhD · Dept Respiratory Medicine, University Hospital, Umeå

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31
Completion
2006-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00338078 on ClinicalTrials.gov